Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

CombinatoRx discontinues development of CRx-140 for psoriasis

Feb. 24, 2006

Positive phase III findings for Desonate HydroGel in atopic dermatitis

Feb. 24, 2006

Clearance for phase II study of CTA-018 in psoriasis

Feb. 24, 2006

New therapeutic agents for acne disclosed in recent Galderma patent

Feb. 21, 2006

Results of studies investigating AAGP effect on cellular growth and function

Feb. 21, 2006

Recent Pfizer patent discloses therapeutic agents for alopecia and acne

Feb. 14, 2006

Avrina shows efficacy in eczema

Feb. 10, 2006

Levulan BLU-U reduces acne lesions in phase II study

Feb. 7, 2006

Updated labeling approved for Elidel and Protopic

Jan. 27, 2006

Novel CCR4 receptor modulators emerge from Astellas R&D

Jan. 18, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...